MedTrace Logo

Rhabdoid Tumors Cellular Architecture by Single-cell Analyses (InnovRT-2)

NCT04987476 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 15

Last updated 2025-11-20

No results posted yet for this study

Summary

The aim is to describe at the cellular level the heterogeneity of rhabdoid tumors, and identify how this diversity influences resistance to treatment.

Conditions

  • ATRT

Interventions

BIOLOGICAL

analyzes in singles cells

genome expression analyzes in single cells

Sponsors & Collaborators

  • Institut Curie

    collaborator OTHER

  • URC-CIC Paris Descartes Necker Cochin

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Kevin Beccaria, MD, PhD, Pr · APHP Assistance Publique des Hôpitaux de Paris

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-31
Primary Completion
2025-02-21
Completion
2025-02-21

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04987476 on ClinicalTrials.gov